1.
The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
by Feldstein, A E
Gut, 2009-11, Vol.58 (11), p.1538-1544
2.
Letter: gender‐associated cell‐free microRNA profiles in non‐alcoholic fatty liver disease – authors' reply
by Newton, K. P.
Alimentary pharmacology & therapeutics, 2014-05, Vol.39 (9), p.999-999
3.
Transcriptional Profile of Genes Involved in Oxidative Stress and Antioxidant Defense in a Dietary Murine Model of Steatohepatitis
by Gornicka, Agnieszka
Antioxidants & redox signaling, 2011-07-15, Vol.15 (2), p.437-445
4.
Behavioral control in alcohol use disorders: relationships with severity
by Claus, Eric D
Journal of studies on alcohol and drugs, 2013-01, Vol.74 (1), p.141-151
5.
Developmental Cognitive Neuroscience of Adolescent Sexual Risk and Alcohol Use
by Feldstein Ewing, Sarah W
AIDS and behavior, 2015-08-20, Vol.20 (Suppl 1), p.97-108
6.
Circulating Levels of FGF-21 in Obese Youth: Associations With Liver Fat Content and Markers of Liver Damage
by Giannini, Cosimo
The journal of clinical endocrinology and metabolism, 2013-07, Vol.98 (7), p.2993-3000
7.
PML targeting eradicates quiescent leukaemia-initiating cells
by Pandolfi, Pier Paolo
Nature, 2008-06-19, Vol.453 (7198), p.1072-1078
8.
Dose specific effects of olanzapine in the treatment of alcohol dependence
by Littlewood, Rae A
Psychopharmacology, 2014-10-12, Vol.232 (7), p.1261-1268
9.
Proposed Model of the Neurobiological Mechanisms Underlying Psychosocial Alcohol Interventions: The Example of Motivational Interviewing
by FELDSTEIN EWING, Sarah W
Journal of studies on alcohol and drugs, 2011, Vol.72 (6), p.903-916
10.
Emerging Role of Redox Dysregulation in Alcoholic and Nonalcoholic Fatty Liver Disease
by Feldstein, Ariel E.
Antioxidants & redox signaling, 2011-07-15, Vol.15 (2), p.421-424
11.
Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019–2020
by Lytle, Kelsey L
Vaccine, 2021-08-31, Vol.39 (37), p.5271-5276
12.
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States
by Kujawski, Stephanie A
Nature medicine, 2020-06, Vol.26 (6), p.861-868
13.
Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion
by Goldhaber, S.Z
The Lancet (British edition), 1993, Vol.341 (8844), p.507-511
14.
Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy
by Van Oekelen, Oliver
Nature medicine, 2021-12, Vol.27 (12), p.2099-2103
15.
350 Stereoelectroencephalography for Refractory Localization-related Epilepsy: Initial Experience in 50 Patients
by Youngerman, Brett E
Neurosurgery, 2017-09-01, Vol.64 (CN_suppl_1), p.279-280
16.
Severity of Liver Injury and Atherogenic Lipid Profile in Children With Nonalcoholic Fatty Liver Disease
by NOBILI, Valerio
Pediatric research, 2010, Vol.67 (6), p.665-670
17.
Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes
by O'Reilly, Richard J
Nature biotechnology, 2003-04, Vol.21 (4), p.405-413
18.
Magnetospheric convection from Cluster EDI measurements compared with the ground-based ionospheric convection model IZMEM
by FÖRSTER, M
Annales geophysicae (1988), 2009, Vol.27 (8), p.3077-3087
19.
Response to Letter to Editor on “Social impairments among children perinatally exposed to oxytocin or oxytocin receptor antagonist”
by Friedlander, E
Early human development, 2017, Vol.112, p.62-63
20.
Auroral electrojets and boundaries of plasma domains in the magnetosphere during magnetically disturbed intervals
by FELDSTEIN, Y. I
Annales geophysicae (1988), 2006, Vol.24 (8), p.2243-2276
